CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SGLT2-HYPE project investigates the effectiveness of a diabetes medication in managing hypertension in older adults. By comparing the drug to a placebo, it aims to provide evidence that could change treatment guidelines and improve patient outcomes.
Hypertension (HTN) is a leading cause of cardiovascular disease (CVD), affecting >80 million EU citizens and >50% of people aged >65 years, resulting in 1 million deaths per year, predominantly from CVD and chronic kidney disease (CKD).
The damage done by CVD costs almost €300 billion annually in the EU alone.
Despite existing therapies, patients with HTN still face substantial risks, due to pre-existing and ongoing end-organ damage due, in part, to inadequate blood pressure (BP) control. SGLT2…
UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN
UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Lubeck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Austria, Innsbruck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
THE GENERAL UNIVERSITY HOSPITAL IN PRAGUE
Czechia, Praha 2
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, Munchen
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
